Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximing Tang

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 6, 2014
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancerEric S Kim, XiMing Tang, Derick R Peterson, et al.
Cell Reports|March 11, 2015
ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and MetastasisJian Liu, Sung-Nam Cho, Bindu Akkanti, et al.
Cancer|October 25, 2011
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcomeLuisa M Solis, Carmen Behrens, M Gabriela Raso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neckCarol M Lewis, Bonnie S Glisson, Lei Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2Robert J G Cardnell, Carmen Behrens, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosisXiming Tang, Humam Kadara, Carmen Behrens, et al.
The Oncologist|August 30, 2014
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancerKathryn A Gold, J Jack Lee, Nusrat Harun, et al.
International Journal of Cancer|November 15, 2017
Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositolNese Unver, Oliver Delgado, Kirubel Zeleke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|May 6, 2014
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancerEric S Kim, XiMing Tang, Derick R Peterson, et al.
Cell Reports|March 11, 2015
ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and MetastasisJian Liu, Sung-Nam Cho, Bindu Akkanti, et al.
Cancer|October 25, 2011
Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcomeLuisa M Solis, Carmen Behrens, M Gabriela Raso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2012
A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neckCarol M Lewis, Bonnie S Glisson, Lei Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2015
An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2Robert J G Cardnell, Carmen Behrens, Lixia Diao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosisXiming Tang, Humam Kadara, Carmen Behrens, et al.
The Oncologist|August 30, 2014
A phase I/II study combining erlotinib and dasatinib for non-small cell lung cancerKathryn A Gold, J Jack Lee, Nusrat Harun, et al.
International Journal of Cancer|November 15, 2017
Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositolNese Unver, Oliver Delgado, Kirubel Zeleke, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 16, 2013
Clinical and biomarker outcomes of the phase II vandetanib study from the BATTLE trialAnne S Tsao, Suyu Liu, J Jack Lee, et al.
Pageof 9